Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Not much more meat left on the bone

View:

Post by Duster340 on Jan 03, 2024 9:43am

Not much more meat left on the bone

(at least in the short term?) the interest in the stock will imediatley be met with the dilution of 65 million shares.

the early exercise of the Warrants during a 30-day early exercise period expected to commence on January 16, 2024

A Conversation With Antibe Therapeutics

Thursday, January 18, 2024 @ 11 am EST

195